I'm something of a message board junkie....no duh!!! And its been my experience that forums for individual stocks typically take on an almost religious fervor to them. Longs dismiss any risks and so called "bashers" almost totally refuse to acknoweldge even the possibility for success.

That's what makes this hub so unique. Longs here, we obviously have a positive bias....we eat our own cooking and go long. But I like seeing the risk factors being discussed without anger and attacks.

It would be nice if we could get periodic updates as to where things stand regarding how many MACE have taken place among both the apelbetalone and placebo groups....but unfortunately that's not the way the trial is structured, so until we get to that halfway point the way I look at it we're flying blind.

I know I mentioned PPHM's recent trial failure which caused their PPS to drop from over $1 to its current 30-40 cent range. In Peregrine's case however there's something of a backstop as I see it because they have a contract manufacturing facility called Avid that has a backlog of almost $60 million and as of Jan 31, 2016 they had cash and cash equivilants of over $65 million.

With Resverlogix I see the risks as being even greater for an even bigger drop if BETONMACE suffers a similar fate to PPHM's phase III trial. Our cash situation is weaker and there isn't a revenue generating operation to fall back on.

My understanding is we started 2016 with $40 million in cash and equivilants....which I assume is Canadian dollars.